Home › Researcher directory › Debu Tripathy

Debu Tripathy

Affiliation : The University of Texas MD Anderson Cancer Center

1Publications (affiliation in the United States)
1394Total publications
34786Citations
79h-index

Research profile

Debu Tripathy has 1 indexed publication (2024). Their work appears in “Molecular Cancer Therapeutics”. Their most cited article, “Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-M” (2024), has been cited 3 times. Their work is co-authored with at least 9 researchers, including institutions in Tunisia.

Is this you? Get your research seen

Create your free DzCademia profile and add your articles: they will show up more easily on Google and in AI assistants like ChatGPT, so more people can read and cite your work.

Create my free profile Add my publications

Research areas

Breast Cancer Treatment Studies
Advanced Breast Cancer Therapies
HER2/EGFR in Cancer Research
Breast Lesions and Carcinomas
PARP inhibition in cancer therapy

Publications (1)

Targeting CDK7 Enhances the Antitumor Efficacy of Enzalutamide in Androgen Receptor–Positive Triple-Negative Breast Cancer by Inhibiting c-MYC–mediated Tumorigenesis
2024 · Molecular Cancer Therapeutics · cited 3 times

Collaborations

Partner institutions : University of Hawaii Cancer Center · Institut Pasteur de Tunis

Co-authors’ countries : Tunisia

Co-authors

Bibliographic data from OpenAlex (open database).